Agree on his points, don't think big pharma leaving is some harbinger of doom.
The continued arrogance of executives at Alnylam never fails to show. Spoke with an RNAi executive last year and he said they have a bad reputation, especially the BD, CEO and legal team.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.